Full Press Release Details
MINNEAPOLIS, Sept. 03, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that management will present at the 2019 Dougherty & Co. Institutional Investor Conference in Minneapolis, Minnesota.
Rick Pauls, President and CEO of DiaMedica Therapeutics will host one-on-one institutional investor meetings throughout the day at the event.
Dougherty & Co. Institutional Investor ConferenceDate:Thursday, September 5, 2019Location:Millennium Hotel (1313 Nicollet Mall, Minneapolis, MN 55403)
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. The Company currently has an ongoing phase II study in acute ischemic stroke and a phase Ib study in chronic kidney disease. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”